IDXX EBITDA | IDEXX LABORATORIES INC /DE

IDEXX LABORATORIES INC /DE (IDXX) EBITDA

2026-06-30: Basis Reported; EBITDA $466.62M*; Operating income $425.57M; Depreciation and amortization $41.05M*.
2026-03-31: Basis Reported; EBITDA $400.27M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $354.33M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $391.47M*; Operating income $354.85M; Depreciation and amortization $36.63M*.

Complete source-backed ebitda history.

Available history: 2008-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$466.62M*	$425.57M	$41.05M*	$1.22B	38.35%*	$24.65M*	$347.16M*	$437.50M	$65.43M	(m)	$78.81M
2026-03-31	Reported	$400.27M	(m)	(m)	(m)	35.09%	$31.98M	$266.25M	$418.08M	$65.79M	(m)	$77.00M
2025-12-31	Reported	$354.33M	(m)	(m)	(m)	32.49%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$391.47M*	$354.85M	$36.63M*	$1.11B	35.42%*	$31.11M*	$402.34M*	$421.88M	$63.41M	(m)	$70.16M
2025-06-30	Reported	$408.82M*	$373.05M	$35.77M*	$1.11B	36.85%*	$34.10M*	$185.74M*	$414.73M	$61.90M	(m)	$68.36M
2025-03-31	Reported	$350.6M	(m)	(m)	(m)	35.11%	$30.03M	$237.96M	$375.05M	$59.06M	(m)	$67.41M
2024-12-31	Reported	$295.39M	(m)	(m)	(m)	30.95%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$338.02M*	$303.89M	$34.13M*	$975.54M	34.65%*	$28.09M*	$220.08M*	$379.50M	$53.98M	(m)	$66.07M
2024-06-30	Reported	$295.99M*	$263.80M	$32.19M*	$1.00B	29.49%*	$33.30M*	$248.31M*	$384.42M	$55.45M	(m)	$55.76M
2024-03-31	Reported	$328.86M	(m)	(m)	(m)	34.11%	$30.27M	$198.59M	(m)	$52.63M	(m)	$59.90M
2023-12-31	Reported	$275.04M	(m)	(m)	(m)	30.51%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$304.27M*	$275.28M	$28.98M*	$915.53M	33.23%*	$34.09M*	$272.43M*	(m)	$47.97M	(m)	$55.66M
2023-06-30	Reported	$324.00M*	$296.14M	$27.86M*	$943.63M	34.34%*	$27.47M*	$200.31M*	(m)	$46.51M	(m)	$61.69M
2023-03-31	Reported	$308.73M	(m)	(m)	(m)	34.30%	$39.51M	$183.91M	(m)	$44.67M	(m)	$53.63M
2022-12-31	Reported	$255.25M	(m)	(m)	(m)	30.81%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$273.38M*	$244.83M	$28.55M*	$841.66M	32.48%*	$37.69M*	$189.00M*	(m)	$48.01M	(m)	$53.24M
2022-06-30	Reported	$207.19M*	$179.07M	$28.12M*	$860.55M	24.08%*	$30.09M*	$65.85M*	(m)	$123.22M	(m)	$39.10M
2022-03-31	Reported	$274.86M	(m)	(m)	(m)	32.86%	$31.84M	$114.71M	(m)	$40.17M	(m)	$47.53M
2021-12-31	Reported	$226.89M	(m)	(m)	(m)	28.32%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$252.43M*	$225.96M	$26.47M*	$810.42M	31.15%*	$45.02M*	$187.21M*	$337.50M	$40.43M	(m)	$43.77M
2021-06-30	Reported	$284.63M*	$259.25M	$25.38M*	$826.14M	34.45%*	$22.58M*	$233.96M*	$336.83M	$37.70M	(m)	$49.13M
2021-03-31	Reported	$272.68M	(m)	(m)	(m)	35.06%	$20.16M	$124.42M	$306.93M	$37.58M	(m)	$35.80M
2020-12-31	Reported	$209.66M	(m)	(m)	(m)	29.08%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$196.51M*	$171.86M	$24.65M*	$721.79M	27.22%*	$19.21M*	$193.12M*	$299.18M	$37.52M	(m)	$17.63M
2020-06-30	Reported	$216.83M*	$193.25M	$23.58M*	$637.59M	34.01%*	$24.56M*	$208.14M*	$258.25M	$31.64M	(m)	$34.83M
2020-03-31	Reported	$167.53M	(m)	(m)	(m)	26.75%	$49.00M	$27.87M	$266.75M	$33.31M	(m)	$24.92M
2019-12-31	Reported	$138.22M	(m)	(m)	(m)	22.83%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$162.25M*	$139.80M	$22.45M*	$605.30M	26.80%*	$37.07M*	$132.26M*	$260.35M	$34.26M	(m)	$23.96M
2019-06-30	Reported	$185.90M*	$164.28M	$21.62M*	$620.10M	29.98%*	$33.78M*	$137.10M*	$262.25M	$32.26M	(m)	$30.42M
2019-03-31	Reported	$154.49M	(m)	(m)	(m)	26.82%	$38.21M	$34.38M	$244.46M	$31.51M	(m)	$22.08M
2018-12-31	Reported	$135.95M	(m)	(m)	(m)	24.75%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$138.23M*	$117.35M	$20.88M*	$545.45M	25.34%*	$31.27M*	$110.71M*	$239.81M	$29.19M	(m)	$15.82M
2018-06-30	Reported	$166.49M*	$145.59M	$20.89M*	$580.75M	28.67%*	$27.65M*	$118.83M*	$248.31M	$29.51M	(m)	$28.63M
2018-03-31	Reported	$133.85M	(m)	(m)	(m)	24.89%	$23.73M	$34.90M	$234.56M	$29.02M	(m)	$14.87M
2017-12-31	Reported	$119.33M	(m)	(m)	(m)	23.58%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$121.14M*	$100.41M	$20.73M*	$491.98M	24.62%*	$15.80M*	$110.68M*	$217.97M	$27.59M	(m)	$21.54M
2017-06-30	Reported	$143.15M*	$122.56M	$20.59M*	$508.94M	28.13%*	$14.92M*	$110.19M*	(m)	$27.00M	(m)	$29.18M
2017-03-31	Reported	$112.55M	(m)	(m)	(m)	24.36%	$23.65M	$31.27M	(m)	$25.79M	(m)	$15.68M
2016-12-31	Reported	$104.07M	(m)	(m)	(m)	23.49%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$108.23M*	$88.46M	$19.77M*	(m)	(m)	$12.09M*	(m)	(m)	$25.67M	(m)	$25.07M
2016-06-30	Reported	$123.83M*	$104.16M	$19.66M*	(m)	(m)	$15.96M*	(m)	(m)	$25.41M	(m)	$29.68M
2016-03-31	Reported	$92.34M	(m)	(m)	(m)	22.11%	$21.91M	(m)	(m)	$24.62M	(m)	$20.28M
2015-12-31	Reported	$84.64M	(m)	(m)	(m)	21.18%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$90.18M*	$71.89M	$18.28M*	(m)	(m)	$20.64M*	(m)	(m)	$24.86M	(m)	$20.60M
2015-06-30	Reported	$105.09M*	$88.30M	$16.79M*	(m)	(m)	$23.86M*	$80.17M*	(m)	$24.32M	(m)	$24.66M
2015-03-31	Reported	$88.96M	(m)	(m)	(m)	23.26%	$23.02M	-$14.64M	(m)	$25.01M	(m)	$20.35M
2014-12-31	Reported	$50.08M	(m)	(m)	(m)	14.23%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$87.71M*	$72.19M	$15.52M*	(m)	(m)	$17.09M*	$93.26M*	(m)	$24.85M	(m)	$16.05M
2014-06-30	Reported	$97.91M*	$83.22M	$14.70M*	(m)	(m)	$14.11M*	$81.76M*	(m)	$25.43M	(m)	$23.50M
2014-03-31	Reported	$83.44M	(m)	(m)	(m)	23.16%	$11.30M	$33.52M	(m)	$23.11M	(m)	$21.15M
2013-12-31	Reported	$74.79M	(m)	(m)	(m)	21.12%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	$79.26M*	$65.48M	$13.77M*	(m)	(m)	$15.28M*	$78.10M*	(m)	$21.57M	(m)	$18.79M
2013-06-30	Reported	$92.61M*	$78.76M	$13.84M*	(m)	(m)	$26.05M*	$81.43M*	(m)	$22.18M	(m)	$24.03M
2013-03-31	Reported	$74.7M	(m)	(m)	(m)	22.49%	$20.13M	$21.05M	(m)	$21.76M	(m)	$15.93M
2012-12-31	Reported	$77.35M	(m)	(m)	(m)	24.21%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	$75.71M*	$62.91M	$12.80M*	(m)	(m)	$18.93M*	$74.69M*	(m)	$20.35M	(m)	$19.64M
2012-06-30	Reported	$88.80M*	$75.82M	$12.99M*	(m)	(m)	$14.86M*	$63.62M*	(m)	$20.06M	(m)	$24.05M
2012-03-31	Reported	$73.11M	(m)	(m)	(m)	22.66%	$9.45M	$15.18M	(m)	$20.56M	(m)	$18.92M
2011-12-31	Reported	$68.11M	(m)	(m)	(m)	22.17%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$68.14M*	$56.10M	$12.04M*	(m)	(m)	$13.75M*	$75.21M*	(m)	$19.41M	(m)	$17.12M
2011-06-30	Reported	$83.18M*	$71.30M	$11.88M*	(m)	(m)	$16.60M*	$63.09M*	(m)	$18.62M	(m)	$22.28M
2011-03-31	Reported	$65M	(m)	(m)	(m)	22.21%	$9.57M	$25.22M	(m)	$17.81M	(m)	$16.57M
2010-12-31	Reported	$62.64M	(m)	(m)	(m)	22.08%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$61.30M*	$49.81M	$11.48M*	(m)	(m)	$11.21M*	$54.90M*	(m)	$17.20M	(m)	$14.55M
2010-06-30	Reported	$66.22M*	$54.84M	$11.39M*	(m)	(m)	$8.96M*	$55.88M*	(m)	$17.21M	(m)	$17.09M
2010-03-31	Reported	$59.67M	(m)	(m)	(m)	22.22%	$8.47M	$19.20M	(m)	$16.71M	(m)	$15.09M
2009-12-31	Reported	$56.7M	(m)	(m)	(m)	20.97%	(m)	(m)	(m)	(m)	(m)	(m)
2009-09-30	Reported	$56.71M*	$44.20M	$12.51M*	(m)	(m)	$15.00M*	$44.62M*	(m)	$16.58M	(m)	$12.28M
2009-06-30	Reported	(m)	$49.18M	(m)	(m)	(m)	(m)	(m)	(m)	$16.59M	(m)	$15.11M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$1.51B	(m)	(m)	(m)	34.97%	$124.68M	$1.18B	$1.64B	$251.21M	(m)	$264.73M
2024-12-31	Reported	$1.26B	(m)	(m)	(m)	32.28%	$120.92M	$929.00M	$1.52B	$219.79M	(m)	$221.96M
2023-12-31	Reported	$1.21B	(m)	(m)	(m)	33.11%	$133.63M	$906.51M	$1.47B	$190.95M	(m)	$216.13M
2022-12-31	Reported	$1.01B	(m)	(m)	(m)	30.01%	$148.84M	$542.98M	$1.36B	$254.82M	(m)	$180.88M
2021-12-31	Reported	$1.04B	(m)	(m)	(m)	32.24%	$119.55M	$755.55M	(m)	$161.01M	(m)	$157.81M
2020-12-31	Reported	$790.52M	(m)	(m)	(m)	29.21%	$106.96M	$648.06M	(m)	$141.25M	(m)	$79.85M
2020-09-30	Rolling	(m)	$625.06M*	(m)	$2.59B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	$593.01M*	(m)	$2.47B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	$564.03M*	(m)	$2.46B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	$640.86M	(m)	(m)	(m)	26.63%	$154.97M	$459.16M	(m)	$133.19M	(m)	$94.43M
2019-12-31	Rolling	(m)	$552.85M*	(m)	$2.41B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	$552.56M*	(m)	$2.35B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	$530.11M*	(m)	$2.29B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	$511.43M*	(m)	$2.25B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	$574.51M	(m)	(m)	(m)	25.96%	$115.75M	$400.08M	(m)	$117.86M	(m)	$80.69M
2018-12-31	Rolling	(m)	$491.33M*	(m)	$2.21B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	$473.80M*	(m)	$2.17B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	$456.86M*	(m)	$2.12B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	$433.83M*	(m)	$2.04B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	$496.17M	(m)	(m)	(m)	25.20%	$74.38M	$373.28M	(m)	$109.18M	(m)	$117.79M
2017-12-31	Rolling	(m)	$413.03M*	(m)	$1.97B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	$399.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	$387.09M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	$368.69M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	$428.46M	(m)	(m)	(m)	24.13%	$64.79M	(m)	(m)	$101.12M	(m)	$99.79M
2016-12-31	Rolling	(m)	$350.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	$333.32M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	$316.76M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	$300.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	$368.87M	(m)	(m)	(m)	23.03%	$82.92M	(m)	(m)	$99.68M	(m)	$81.01M
2015-12-31	Rolling	(m)	$299.91M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	$267.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	$268.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	$263.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	$319.14M	(m)	(m)	(m)	21.48%	$60.52M	$235.85M	(m)	$98.26M	(m)	$64.60M
2014-12-31	Rolling	(m)	$260.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	$286.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	$280.08M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	$275.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	$321.36M	(m)	(m)	(m)	23.34%	$77.61M	$246.00M	(m)	$88.00M	(m)	$75.47M
2013-12-31	Rolling	(m)	$266.76M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	$268.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	$266.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	$263.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	$314.97M	(m)	(m)	(m)	24.35%	$57.62M	$222.41M	(m)	$82.01M	(m)	$82.33M
2012-12-31	Rolling	(m)	$262.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	$254.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Rolling	(m)	$247.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	$243.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	$284.43M	(m)	(m)	(m)	23.34%	$49.68M	$217.91M	(m)	$76.04M	(m)	$72.67M
2011-12-31	Rolling	(m)	$236.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Rolling	(m)	$231.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-06-30	Rolling	(m)	$225.45M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-03-31	Rolling	(m)	$208.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$249.84M	(m)	(m)	(m)	22.64%	$38.91M	$178.83M	(m)	$68.60M	(m)	$60.81M
2010-12-31	Rolling	(m)	$203.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2009-12-31	Reported	$225.74M	(m)	(m)	(m)	21.88%	$50.66M	$174.95M	(m)	$65.12M	(m)	$52.30M
2008-12-31	Reported	$220.44M	(m)	(m)	(m)	21.53%	$89.97M	$143.31M	(m)	$70.67M	(m)	$54.02M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lantheus Holdings, Inc. (LNTH)	United States	$6.510B	26.31
NEOGEN CORP (NEOG)	United States	$2.979B	-247.49
Celldex Therapeutics, Inc. (CLDX)	United States	$2.471B	-9.72
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10